Effects of Intermittent Fasting on Liver Steatosis and Fibrosis, Serum FGF-21 and Autophagy Markers in Metabolic Dysfunction-Associated Fatty Liver Disease: A Randomized Controlled Trial
Background: This randomized controlled study sought to determine the effect of intermittent fasting on anthropometric measurements, fibroblast growth factor (FGF)-21, and autophagy markers, as well as on hepatic steatosis and fibrosis levels in overweight or obese patients with metabolic dysfunction...
Saved in:
| Main Authors: | Tugce Ozlu Karahan, Elvan Yilmaz Akyuz, Demet Yilmaz Karadag, Yusuf Yilmaz, Fatih Eren |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-04-01
|
| Series: | Life |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2075-1729/15/5/696 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Intermittent fasting and neurocognitive disorders: What the evidence shows
by: Jordan Beveridge, et al.
Published: (2025-04-01) -
Intermittent fasting and a no-sugar diet for Long COVID symptoms: a randomized crossover trial
by: Thomas Bunker, et al.
Published: (2025-07-01) -
Effects of time-restricted feeding (TRF)-model of intermittent fasting on adipose organ: a narrative review
by: Zahra Bahadoran, et al.
Published: (2024-12-01) -
The ups and downs of caloric restriction and fasting: from molecular effects to clinical application
by: Sebastian J Hofer, et al.
Published: (2021-11-01) -
What are the effects of time‐restricted eating upon metabolic health outcomes in individuals with metabolic syndrome: A scoping review
by: Rory J. Heath, et al.
Published: (2025-05-01)